These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3582103)

  • 1. Prevention of IOP-rise following Nd-YAG laser capsulotomy with pre-operative timolol eye-drops and 1 tablet acetazolamide 250 mg systematically.
    Boen-Tan TN; Stilma JS
    Doc Ophthalmol; 1986 Dec; 64(1):59-67. PubMed ID: 3582103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of IOP-rise following Nd-YAG laser capsulotomy with topical timolol and indomethacin.
    Van der Feltz van der Sloot D; Stilma JS; Boen-Tan TN; Bezemer PD
    Doc Ophthalmol; 1988; 70(2-3):209-14. PubMed ID: 3234187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic use of timolol maleate to prevent intraocular pressure elevation after Nd-YAG laser posterior capsulotomy.
    Cai JP; Cheng JW; Wei RL; Ma XY; Jiang F; Zhu H; Li Y
    Int Ophthalmol; 2008 Feb; 28(1):19-22. PubMed ID: 17585375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical 2.0% dorzolamide vs oral acetazolamide for prevention of intraocular pressure rise after neodymium:YAG laser posterior capsulotomy.
    Ladas ID; Baltatzis S; Panagiotidis D; Zafirakis P; Kokolakis SN; Theodossiadis GP
    Arch Ophthalmol; 1997 Oct; 115(10):1241-4. PubMed ID: 9338667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levobunolol 0.5% and timolol 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy.
    Rakofsky S; Koch DD; Faulkner JD; Terry SA; Mandell AI; Gross RL; Kelley EP; Iacono TL; Lue J
    J Cataract Refract Surg; 1997 Sep; 23(7):1075-80. PubMed ID: 9379380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of 0.25% apraclonidine in preventing intraocular pressure elevation after Nd:YAG laser posterior capsulotomy.
    Simsek S; Ertürk H; Demirok A; Cinal A; Yasar T; Karadenizli C
    Eur J Ophthalmol; 1998; 8(3):167-72. PubMed ID: 9793771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intraocular pressure changes after Nd:YAG laser capsulotomy with preoperative use of timolol].
    Yang W; Liu Y; Li S
    Yan Ke Xue Bao; 1991 Jun; 7(2):86-8. PubMed ID: 1669483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic use of acetazolamide to prevent intraocular pressure elevation following Nd-YAG laser posterior capsulotomy.
    Ladas ID; Pavlopoulos GP; Kokolakis SN; Theodossiadis GP
    Br J Ophthalmol; 1993 Mar; 77(3):136-8. PubMed ID: 8457502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of intraocular pressure elevation following neodymium-YAG laser posterior capsulotomy.
    Richter CU; Arzeno G; Pappas HR; Arrigg CA; Wasson P; Steinert RF
    Arch Ophthalmol; 1985 Jul; 103(7):912-5. PubMed ID: 3839390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term elevation of intraocular pressure after neodymium: YAG laser posterior capsulotomy.
    Jahn CE; Emke M
    Ophthalmologica; 1996; 210(2):85-9. PubMed ID: 9148259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraocular pressure changes after neodymium-YAG laser capsulotomy in eyes pretreated with timolol.
    Migliori ME; Beckman H; Channell MM
    Arch Ophthalmol; 1987 Apr; 105(4):473-5. PubMed ID: 3566598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy.
    Unal M; Yücel I; Akar Y
    J Cataract Refract Surg; 2006 Sep; 32(9):1499-502. PubMed ID: 16931262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neodymium:yttrium-aluminum-garnet capsulotomy and intraocular pressure in pseudophakic patients with glaucoma.
    Barnes EA; Murdoch IE; Subramaniam S; Cahill A; Kehoe B; Behrend M
    Ophthalmology; 2004 Jul; 111(7):1393-7. PubMed ID: 15234143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timolol and intra-ocular pressure elevation following neodymium: YAG laser surgery.
    Stilma JS; Boen-Tan TN
    Doc Ophthalmol; 1986 Jan; 61(3-4):233-9. PubMed ID: 3753927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 0.2% brimonidine in preventing intraocular pressure elevation after Nd:YAG laser posterior capsulotomy.
    Seong GJ; Lee YG; Lee JH; Lim SJ; Lee SC; Hong YJ; Kwon OW; Kim HB
    Ophthalmic Surg Lasers; 2000; 31(4):308-14. PubMed ID: 10928668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of topical brimonidine to prevent intraocular pressure elevations following Nd:YAG-laser posterior capsulotomy.
    Gartaganis SP; Mela EK; Katsimpris JM; Petropoulos JK; Karamanos NK; Koliopoulos JX
    Ophthalmic Surg Lasers; 1999; 30(8):647-52. PubMed ID: 10507567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brimonidine 0.2% versus brimonidine Purite 0.15%: prophylactic effect on iop elevation after Nd:YAG laser posterior capsulotomy.
    Yeom HY; Lee JH; Hong YJ; Seong GJ
    J Ocul Pharmacol Ther; 2006 Jun; 22(3):176-81. PubMed ID: 16808678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pilocarpine in treatment of intraocular pressure elevation following neodymium: YAG laser posterior capsulotomy.
    Brown SV; Thomas JV; Belcher CD; Simmons RJ
    Ophthalmology; 1985 Mar; 92(3):354-9. PubMed ID: 3991123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nd:YAG laser posterior capsulotomy does not produce elevation of intraocular pressure in cynomolgus monkeys.
    Camras CB; Rosenthal JS; Podos SM
    Ophthalmic Surg; 1988 Jun; 19(6):403-7. PubMed ID: 3419775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermediate-term changes in intraocular pressure after neodymium-YAG laser posterior capsulotomy.
    Leys MJ; Pameijer JH; de Jong PT
    Am J Ophthalmol; 1985 Aug; 100(2):332-3. PubMed ID: 3839628
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.